Ischemic heart disease still represents a large burden on individuals and health care
resources worldwide. By conventions, it is equated with atherosclerotic plaque due to flow …

As early and effective antiretroviral therapy has become more widespread, HIV has
transitioned from a progressive, fatal disease to a chronic, manageable disease marked by …

Background: With advances in antiretroviral therapy, most deaths in people with HIV are
now attributable to noncommunicable illnesses, especially cardiovascular disease. We …

Thromboembolic conditions were estimated to account for 1 in 4 deaths worldwide in 2010
and are the leading cause of mortality. Thromboembolic conditions are divided into arterial …

Background People living with HIV (PLWH) experience higher risk of myocardial infarction
(MI) and heart failure (HF) compared with uninfected individuals. Risk of other …

HIV-related cardiovascular disease research is predominantly from Europe and North
America. Of the estimated 37· 9 million people living with HIV worldwide, 25· 6 million live in …

Cardiovascular disease is one of the leading causes of morbidity and mortality in people
living with HIV. Several epidemiological studies have shown an increased risk of myocardial …

Objective: Given conflicting data regarding the association of HIV infection and ischemic
stroke risk, we sought to determine whether HIV infection conferred an increased ischemic …

The prevalence of HIV (human immunodeficiency virus) associated neurocognitive
disorders (HAND) will undoubtedly increase with the improved longevity of HIV‐infected …

Importance The vascular risk attributable to HIV infection is rising. The heterogeneity of the
samples studied is an obstacle to understanding whether HIV is a vascular risk across …